AI assistant
DIMERIX LIMITED — Capital/Financing Update 2008
Jul 14, 2008
64804_rns_2008-07-14_f8d2674f-a306-40b0-80e7-c6176902c010.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [228 x 84] intentionally omitted <==
15 July 2008
The Manager Company Announcements Platform ASX Limited
Dear Sir/Madam
Dispatch of renounceable Rights Issue Prospectus
Sun Biomedical Limited confirms that copies of the renounceable Rights Issue Prospectus dated 26 June 2008 together with personalised Entitlement and Acceptance Forms were dispatched to all Eligible Shareholders today.
As announced on 26 June 2008, Eligible Shareholders will be given the opportunity to subscribe for:
-
(a) 4 New Ordinary Shares for every 5 Shares held at $0.01 per New Ordinary Share; together with
-
(b) one free attaching Option with an exercise price of $0.02 expiring 30 November 2010 on the basis of 1 Option for every 2 New Ordinary Shares subscribed for.
The Minimum Subscription of $2,000,000 is underwritten by Patersons Securities Limited.
For further information see www.sunbiomed.com or contact:
Jim Hallam Director Mobile: 0414 965 442
Sun Biomedical Investor Communications Limited Computershare T: +61 1300 728 275 | F: +61 3 9473 2500 | ABN 18 001 285 230 E: [email protected]
ASX:SBN www.sunbiomed.com